IP Verse

Methods And Pharmaceutical Compositions For Expressing A Polynucleotide Of Interest In The Peripheral Nervous System Of A Subject - EP3320101

The patent EP3320101 was granted to Assistance Publique Hpitaux DE Paris Aphp on Aug 11, 2021. The application was originally filed on Jul 6, 2016 under application number EP16736134A. The patent is currently recorded with a legal status of "Revoked".

EP3320101

ASSISTANCE PUBLIQUE HPITAUX DE PARIS APHP
Application Number
EP16736134A
Filing Date
Jul 6, 2016
Status
Revoked
Mar 29, 2025
Grant Date
Aug 11, 2021
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

STRAWMANMay 11, 2022LONGLANDADMISSIBLE

Patent Citations (16) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
DESCRIPTIONUS2011301073
DESCRIPTIONUS5139941
DESCRIPTIONUS5173414
DESCRIPTIONUS53222
DESCRIPTIONUS53223
DESCRIPTIONUS53224
DESCRIPTIONUS53225
DESCRIPTIONWO9201070
DESCRIPTIONWO9303769
INTERNATIONAL-SEARCH-REPORTUS2013039888
INTERNATIONAL-SEARCH-REPORTUS2013225666
INTERNATIONAL-SEARCH-REPORTWO2011133890
OPPOSITIONUS2013039888
OPPOSITIONUS2013225666
OPPOSITIONWO2011133890
OPPOSITIONWO2015031392

Non-Patent Literature (NPL) Citations (17) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
DESCRIPTION- APFEL, S. C. ET AL., ANNALS OF NEUROLOGY, (1992), vol. 31, pages 76 - 80-
DESCRIPTION- HOMS J; ARIZA L; PAGES G; UDINA E; NAVARRO X; CHILLON M; BOSCH A, GENE THER., (201106), vol. 18, no. 6, pages 622 - 30-
DESCRIPTION- LEGHA, S., MEDICAL TOXICOLOGY, (1986), vol. 1, pages 421 - 427-
DESCRIPTION- MOUMAN, J. E., NEW ENG JOUR MED., (1990), vol. 322, pages 126 - 127-
DESCRIPTION- OLESEN ET AL., DRUG SAFETY, (1991), vol. 6, pages 302 - 314-
DESCRIPTION- BARASH ET AL., "Human secretory signal peptide description by hidden Markov model and generation of a strong artificial signal peptide for secreted protein expression", BIOCHEM. BIOPHYS. RES. COMM., (2002), vol. 294, doi:doi:10.1016/S0006-291X(02)00566-1, pages 835 - 42, XP002292654
EXAMINATION- HOYNG S A ET AL, "Gene delivery to rat and human Schwann cells and nerve segments: a comparison of AAV 1-9 and lentiviral vectors", GENE THERAPY, NATURE PUBLISHING GROUP, LONDON, GB, vol. 22, no. 10, doi:10.1038/GT.2015.47, ISSN 0969-7128, (20150504), pages 767 - 780, (20150504), XP036974032
INTERNATIONAL-SEARCH-REPORT- BOULIS NICHOLAS M ET AL, "Adeno-associated viral vector gene expression in the adult rat spinal cord following remote vector delivery", NEUROBIOLOGY OF DISEASE, BLACKWELL SCIENTIFIC PUBLICATIONS, OXFORD, GB, (20031201), vol. 14, no. 3, doi:10.1016/J.NBD.2003.08.025, ISSN 0969-9961, pages 535 - 541, XP002474413 [A] 1-13 * the whole document *
INTERNATIONAL-SEARCH-REPORT- C N MATTAR ET AL, "Systemic delivery of scAAV9 in fetal macaques facilitates neuronal transduction of the central and peripheral nervous systems", GENE THERAPY, GB, (20130101), vol. 20, no. 1, doi:10.1038/gt.2011.216, ISSN 0969-7128, pages 69 - 83, XP055221970 [A] 1-13 * the whole document *
INTERNATIONAL-SEARCH-REPORT- J HOMS ET AL, "Schwann cell targeting via intrasciatic injection of AAV8 as gene therapy strategy for peripheral nerve regeneration", GENE THERAPY, GB, (20110217), vol. 18, no. 6, doi:10.1038/gt.2011.7, ISSN 0969-7128, pages 622 - 630, XP055221988 [AD] 1-13 * the whole document *
INTERNATIONAL-SEARCH-REPORT- MAI K. ELMALLAH ET AL, "Retrograde Gene Delivery to Hypoglossal Motoneurons Using Adeno-Associated Virus Serotype 9", HUMAN GENE THERAPY METHODS, (20120401), vol. 23, no. 2, doi:10.1089/hgtb.2012.009, ISSN 1946-6536, pages 148 - 156, XP055221967 [A] 1-13 * the whole document *
OPPOSITION- MATTAR et al., "Systemic delivery of scAAV9 in fetal macaques facilitates neuronal transduction of the central and peripheral nervous systems", Gene Therapy, (20130000), vol. 20, doi:10.1038/gt.2011.216, XP055221970
OPPOSITION- Homs J, Ariza L, Pagès G, Udina E, Navarro X, Chillón M, Bosch A, "Schwann cell targeting via intrasciatic injection of AAV8 as gene therapy strategy for peripheral nerve regeneration", Gene Therapy, (20110000), vol. 18, no. 6, pages 622 - 630, XP037773589
OPPOSITION- Hoyng S A, De Winter F, Gnavi S, Van Egmond L, Attwell C L, Tannemaat M R, Verhaagen J, Malessy M J A, "Gene delivery to rat and human Schwann cells and nerve segments: a comparison of AAV 1-9 and lentiviral vectors", Gene Therapy, (20150000), pages 767 - 780, XP037772928
OPPOSITION- Hirai Takashi, Enomoto Mitsuhiro, Kaburagi Hidetoshi, Sotome Shinichi, Yoshida-Tanaka Kie, Ukegawa Madoka, Kuwahara Hiroya, Yamamoto Mariko, Tajiri Mio, Miyata Haruka, Hirai Yukihiko, Tominaga Makoto, Shinomiya Kenichi, Mizusawa Hidehiro, Okawa Atsushi, Yokota Takanori, "Intrathecal AAV Serotype 9-mediated Delivery of shRNA Against TRPV1 Attenuates Thermal Hyperalgesia in a Mouse Model of Peripheral Nerve Injury", Molecular Therapy, ( ), vol. 22, no. 2, pages 409 - 419, XP055925664
OPPOSITION- ELMALLAH et al., "Retrograde Gene Delivery to Hypoglossal Motoneurons Using Adeno-Associated Virus Serotype 9", Human Gene Therapy Methods, (20120400), vol. 23, doi:10.1089/hgtb.2012.009, pages 148 - 156, XP055221967
OPPOSITION- HIRAI et al., "Intrathecal shRNA-AAV9 Inhibits Target Protein Expression in the Spinal Cord and Dorsal Root Ganglia of Adult Mice", Human Gene Therapy Methods, (20120400), vol. 23, doi:10.1089/hgtb.2012.035, pages 119 - 127, XP055279594

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents